Combination Therapy

Combination therapy amplifies the effectiveness of cancer treatment by pairing VE3 with existing standard-of-care options. By targeting ALDH1A3, VE3 reduces cancer stem cell resilience and therapy resistance, enabling a synergistic effect that improves overall treatment efficacy and patient outcomes.